Streetbeat News

Earnings

RDHL

RedHill Biopharma reported a FY23 EPS of $0.01, an improvement from last year's $(0.12), but saw a significant revenue decline to $6.5M from $61.8M YoY.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 1:26 pm

NFLX

Netflix Inc (NASDAQ:NFLX) is set to release its Q1 earnings on April 18, with the stock outperforming the S&P 500 Index year-to-date. JPMorgan analyst Doug Anmuth is bullish on Netflix, raising the price target from $610 to $650, citing strong growth prospects, the Paid Sharing initiative, and a robust content slate. Anmuth's optimism is based on potential revenue acceleration, subscriber growth, and strategic ad tier expansion, projecting significant growth in earnings and operating income through 2024 and 2025.

Portfolio Pulse from Surbhi Jain

April 08, 2024 | 1:25 pm

RHE

Regional Health Props (AMEX:RHE) reported a significant improvement in its Q4 EPS, moving from $(2.53) to $(0.13) YoY. However, sales decreased by 55.47% from $10.15M to $4.52M YoY.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 1:15 pm

CELU

Celularity Inc. (NASDAQ:CELU), a biotech company, announced it will present in vitro data at the ASGCT Annual Meeting, suggesting its NK cell therapies (CYNK-001 and CYNK-201) could effectively eliminate senescent cells, potentially addressing age-related diseases. These cells contribute to degenerative diseases, cancer, and immune system decline with age. Celularity's technology leverages placental cells for cell therapy products targeting damaged and abnormal cells.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 1:03 pm

AMLX

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) announced a virtual webcast to discuss interim data from the Phase 2 HELIOS trial of AMX0035 for Wolfram syndrome treatment, set for April 10, 2024. The webcast will feature management and Dr. Fumihiko Urano, the trial's Principal Investigator. The HELIOS trial aims to study AMX0035's safety, tolerability, and its impact on endocrinological, neurological, and ophthalmologic functions in Wolfram syndrome patients.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 1:01 pm

AAPL

BTCUSD

ETHUSD

TSLA

The article covers a range of topics from cryptocurrency trends, including Bitcoin's surge as its halving approaches, to US and world politics, the US economy, tech innovations, electric vehicles, and more. Key highlights include Bitcoin, Ethereum, and Dogecoin's price movements, Ripple CEO's market prediction, and various political and economic developments in the US and globally. It also touches on tech updates like Apple's new initiatives and Tesla's focus on autonomy.

Portfolio Pulse from Akanksha Bakshi

April 08, 2024 | 12:49 pm

APA

DHI

HUBS

INTC

Wall Street's most accurate analysts have made new stock picks, with significant upside potential identified in companies like Intel, HubSpot, APA Corporation, D.R. Horton, and Worthington Steel. These picks come amidst a backdrop of the Dow Jones experiencing its worst weekly performance in 2024. Analysts from firms such as Canaccord Genuity, Roth MKM, Wedbush, Keybanc, and Truist Securities have maintained or adjusted their ratings on these stocks, citing various corporate developments and financial results.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 12:46 pm

AXTI

AXT has announced its preliminary revenue for Q1 2024, projecting between $22.4M and $22.7M, surpassing the estimated $20.964M. This indicates a positive performance against market expectations.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:46 pm

AZZ

GAST

MGMT

AZZ Inc. (NYSE:AZZ) has raised its FY25 sales and profit forecasts due to strong performance in several end markets. The company now expects sales between $1.525 billion and $1.625 billion, and adjusted EPS between $4.50 and $5.00. Adjusted EBITDA forecast has also been increased to $310 million - $360 million. AZZ plans to further deleverage by $60 million - $90 million and has seen a credit rating upgrade by S&P Global. The company focuses on organic growth in its Metal Coatings and Precoat Metals segments. AZZ shares rose 1.82% in premarket trading. Exposure to AZZ stock can also be gained through Ballast Small/Mid Cap ETF (NYSE:MGMT) and Gabelli Automation ETF (NYSE:GAST).

Portfolio Pulse from Lekha Gupta

April 08, 2024 | 12:43 pm

MULN

Mullen Automotive, Inc. (MULN) announces significant cost reduction and consolidation measures expected to save approximately $170 million over the next 12 months. The company is focusing on the commercial EV segment, aiming to sell 100 units in April, as part of its strategy to align with current market conditions and drive near-term revenue. These actions include prioritizing commercial programs, integrating engineering centers, and expanding the dealer network, aiming for long-term growth and improved financial results.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:43 pm